These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37429270)

  • 1. Lemborexant Attenuates Regurgitation without Worsening Objective Parameters on Reflux Monitoring in Patients with Gastroesophageal Reflux Disease and Insomnia: A Single-Arm Proof-of-Concept Study.
    Hoshikawa Y; Momma E; Kawami N; Iwakiri K
    Digestion; 2023; 104(6):438-445. PubMed ID: 37429270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Ramelteon on Heartburn Symptoms of Patients With Gastroesophageal Reflux Disease and Chronic Insomnia: A Pilot Study.
    Jha LK; Fass R; Gadam R; Maradey-Romero C; Nasrollah L; Hershcovici T; Quan SF; Dickman R
    J Clin Gastroenterol; 2016 Feb; 50(2):e19-24. PubMed ID: 25887111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time.
    Frazzoni L; Frazzoni M; de Bortoli N; Tolone S; Furnari M; Martinucci I; Bertani H; Marchi S; Conigliaro R; Fuccio L; Savarino V; Savarino E
    Neurogastroenterol Motil; 2017 Nov; 29(11):. PubMed ID: 28543861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between post-reflux swallow-induced peristaltic wave index and esophageal mucosal integrity in patients with GERD symptoms.
    Ribolsi M; Frazzoni M; Cicala M; Savarino E
    Neurogastroenterol Motil; 2023 Jan; 35(1):e14344. PubMed ID: 35238440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
    Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
    JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives.
    Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Savarino V; Savarino E
    Dig Dis Sci; 2017 Aug; 62(8):1881-1889. PubMed ID: 28550489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of improvement of impaired chemical clearance characterizes PPI-refractory reflux-related heartburn.
    Frazzoni M; Frazzoni L; Tolone S; De Bortoli N; Savarino V; Savarino E
    Am J Gastroenterol; 2018 May; 113(5):670-676. PubMed ID: 29681623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of antireflux treatment on the frequency of awakenings from sleep in patients with Gastroesophageal reflux disease.
    Jha LK; Maradey-Romero C; Gadam R; Hershcovici T; Fass OZ; Quan SF; Guillen J; Fass R
    Neurogastroenterol Motil; 2015 Feb; 27(2):237-45. PubMed ID: 25484104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance.
    de Bortoli N; Gyawali CP; Frazzoni M; Tolone S; Frazzoni L; Vichi E; Visaggi P; Bellini M; Marabotto E; Penagini R; Savarino V; Marchi S; Savarino EV
    Neurogastroenterol Motil; 2020 Dec; 32(12):e13919. PubMed ID: 32573065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Modifying Amount and Type of Dietary Carbohydrate on Esophageal Acid Exposure Time and Esophageal Reflux Symptoms: A Randomized Controlled Trial.
    Gu C; Olszewski T; King KL; Vaezi MF; Niswender KD; Silver HJ
    Am J Gastroenterol; 2022 Oct; 117(10):1655-1667. PubMed ID: 35973185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease.
    Frazzoni M; Savarino E; de Bortoli N; Martinucci I; Furnari M; Frazzoni L; Mirante VG; Bertani H; Marchi S; Conigliaro R; Savarino V
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):40-6. PubMed ID: 26122764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring.
    Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Furnari M; Martinucci I; Mirante VG; Marchi S; Savarino V; Savarino E
    Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 27620303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the treatment effectiveness between lemborexant and zolpidem tartrate extended-release for insomnia disorder subtypes defined based on polysomnographic findings.
    Inoue Y; Nishida M; Kubota N; Koebis M; Taninaga T; Muramoto K; Ishikawa K; Moline M
    J Clin Sleep Med; 2023 Mar; 19(3):519-528. PubMed ID: 36472134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
    de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
    World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of recumbent reflux by multichannel intraluminal impedance pH testing for patients with gastroesophageal reflux disease and sleep disturbance.
    Hoshino M; Omura N; Yano F; Tsuboi K; Yamamoto SR; Akimoto S; Masuda T; Kashiwagi H; Yanaga K
    Esophagus; 2020 Jul; 17(3):348-354. PubMed ID: 31970574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn.
    Frazzoni M; de Bortoli N; Frazzoni L; Furnari M; Martinucci I; Tolone S; Farioli A; Marchi S; Fuccio L; Savarino V; Savarino E
    J Gastroenterol; 2017 Apr; 52(4):444-451. PubMed ID: 27241210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent Postprandial Regurgitation vs Rumination in Patients With Refractory Gastroesophageal Reflux Disease Symptoms: Identification of a Distinct Rumination Pattern Using Ambulatory Impedance-pH Monitoring.
    Nakagawa K; Sawada A; Hoshikawa Y; Nikaki K; Sonmez S; Woodland P; Yazaki E; Sifrim D
    Am J Gastroenterol; 2019 Aug; 114(8):1248-1255. PubMed ID: 31246694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of zolpidem on the sleep arousal response to nocturnal esophageal acid exposure.
    Gagliardi GS; Shah AP; Goldstein M; Denua-Rivera S; Doghramji K; Cohen S; Dimarino AJ
    Clin Gastroenterol Hepatol; 2009 Sep; 7(9):948-52. PubMed ID: 19426833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms.
    Yuan YZ; Fang JY; Zou DW; Levinson N; Jenner B; Wilkinson J
    J Dig Dis; 2016 Nov; 17(11):725-734. PubMed ID: 27622897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.